|Articles|September 18, 2020
Central Laboratory Capabilities for Immuno-Oncology Trials
Author(s)Cerba Research
For immuno-oncology trials, partner with a global central lab that can generate early insights to optimize your protocol and ramp up to commercial scale while preserving budgets and timelines.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Novartis Calls for Global Governments to Address Global Trade Policy
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
4
Generative AI and Adaptive Trials Shape Future Biotech Development
5